Clinical trial
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients…
NCT00004124 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00004124 |
|---|---|
| Title | S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer |
| Official title | Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High-Risk Prostate Cancer Patients Following Radical Prostatectomy |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | bicalutamide, goserelin, mitoxantrone hydrochloride, prednisone |
| Enrollment | 983 |
| Start date | Oct 15, 1999 |
| Primary completion | Aug 12, 2017 |
| Completion | May 1, 2018 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 30, 2022 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: